Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,674 | -1,237 | -5,467 | -4,347 | -3,242 |
| Depreciation Amortization | 27 | 13 | 54 | 40 | 27 |
| Other Working Capital | 74 | 426 | -698 | -511 | -269 |
| Other Operating Activity | 367 | 194 | 903 | 483 | 398 |
| Operating Cash Flow | $-1,206 | $-604 | $-5,209 | $-4,334 | $-3,087 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 188 | 807 | 802 |
| Common Stock Repurchased | N/A | N/A | 617 | N/A | N/A |
| Other Financing Activity | 635 | 645 | 819 | 838 | 848 |
| Financing Cash Flow | $635 | $645 | $1,624 | $1,645 | $1,651 |
| Exchange Rate Effect | -33 | -31 | -34 | 88 | -9 |
| Beginning Cash Position | 5,002 | 4,956 | 8,622 | 8,649 | 8,595 |
| End Cash Position | 4,398 | 4,966 | 5,004 | 6,048 | 7,150 |
| Net Cash Flow | $-605 | $10 | $-3,619 | $-2,601 | $-1,446 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,206 | -604 | -5,209 | -4,334 | -3,087 |
| Free Cash Flow | -1,206 | -604 | -5,209 | -4,334 | -3,087 |